COLL vs CPT · P/E 17, rev $181.9M vs P/E 104, rev $7.1M
Collegium Pharmaceutical Inc (COLL) versus Camden Property Trust (CPT) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Camden Property Trust (CPT) is a reit - residential company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported CPT revenue for 2024-12-31 was $7.1M. Net income was $170.8M. Revenue was up 106.8% from 2023-12-31 to 2024-12-31. CPT currently screens at market cap $12.11B and trailing P/E 104.0.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. CPT currently screens at market cap $12.11B and trailing P/E 104.0.
Not investment advice. Open the COLL and CPT stock pages for the full models.
Not investment advice.